| | | Trans13-204 | | Special Topics – Rectal Microbicides Speakers: Ian McGowan, MD, PhD; David Nalos HIV prevention that Gels: Rectal microbicides for transgender communities. These voices are vital to shape a rectal microbicide research agenda that is inclusive and responsive to the needs
of transgender communities. During this session, experts will provide an in-depth and up-to-date discussion of the
science, community challenges, and advocacy related to rectal microbicides as an alternative HIV prevention strategy for transgender people who practice anal sex. Attendees will have an opportunity to view a newly launched educational video on rectal microbicides, and leave with new knowledge about the status of HIV prevention research and how to overcome
the barriers that may be preventing transgender communities from becoming involved in this promising research area. | | MP3 | | $10.00 | | $10.00 | |
| | | Trans13-109 | | Policy Institute – Transgender Health Coverage Speakers: André Wilson, MS; Jamison Green, PhD; Cecilia Chung; Susanne Watson, PhD Challenges and work-arounds in implementation.
We will discuss the continuing barriers to access reported by healthcare providers and patients alike both in inclusive
plans and those with exclusions: challenges in prior authorization and claims processing, limited provider networks,
and outdated insurer medical guidelines. We will provide information on documentation, procedure and diagnosis
codes so providers can minimize denials and succeed with billing and appeals, and discuss strategies for direct
advocacy with insurers.
We will continue with an overview of progress towards inclusion, best practices and indispensable advocacy tools
such as the Human Rights Campaign (HRC) Equality Indexes (MEI, CEI) and professional association interventions.
Comparing progress towards trans*-inclusive benefits in the healthcare industry with other professional sectors. The role healthcare providers can play in eliminating exclusions in their own sector. Outdated
medical policies currently used by most insurers remain a central barrier. We will discuss our draft “Model Guideline” and issues posed by utilization management systems. We will also look at the progress made by the Healthy San Francisco program, and by Kaiser Permanente. | | MP3 | | $10.00 | | $10.00 | |
